Juvenile Myositis Center of Excellence
The Juvenile Myositis Center of Excellence cares for patients with juvenile myositis and juvenile dermatomyositis, rare autoimmune conditions that can cause severe muscle inflammation and skin rashes.
Our program was founded by specialists with decades of experience in studying and treating juvenile myositis, and the team focuses on providing wraparound care – a dynamic process of working with families to meet their specific needs and build on their strengths. We support our young patients from diagnosis and treatment through follow-up and monitoring. Our standards of care have earned us a center of excellence designation from Cure JM, an organization that funds research and education on juvenile myositis.
Our physician-scientists also maintain an active research program that includes both studies on the biological underpinnings of juvenile myositis and clinical trials to evaluate promising new treatments. We are dedicated to translating the latest science into better therapeutic options and health outcomes for our patients.
Our locations (2)
Our research initiatives
Patient stories
Back to school while healing from rare disease
Juvenile dermatomyositis had Annabel in severe pain and distress. With a care team that prioritized her mental health as much as her physical recovery, she is back to swimming – and smiling.
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Clinical trials
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents W...
CRR is defined as achievement of all of the following: - Urinary protein-to-creatinine ratio (UPCR) <0.5 g/g - Estimated Glomerular Filtration Rate (eGFR) >=85% of baseline - No occurrence of intercurrent events
Recruiting
More about this study
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Recruiting
More about this study
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
the percentage of subjects achieving at least partial remission of LN (PRR) as per the adapted ACR/EULAR Criteria at Week 26
Recruiting
More about this studySaving future lives
500+ UCSF investigators are researching cures for hundreds of childhood and adult diseases.
